Abstract
In order to know the prevalence and risk factors for coinfections by human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among injecting drug users (IDUs), a cross-sectional study was carried out in two prisons of the province of Cantabria, northern Spain. Three hundred and sixty-two IDU inmates were recruited. All inmates were interviewed and their blood tested for HIV, HBV and HCV. Crude and multiple risk factor adjusted for (by polychotomous logistic regression) odds ratios were calculated. Prevalence of HBV-HCV coinfection (42.5%) was higher than HIV-HBV-HCV coinfection (37.3%), whereas monoinfections were very uncommon (overall: 13%). Long-term injectors and reincarceration were the foremost risk factors for both coinfections, showing a trend between the degree of association and the number of viruses infecting a patient. No significant relationship between coinfection status and sexual practices was observed. The results related to coinfections are consistent with previous studies of prevalence and risk factors for HIV, HBV and HCV, in indicating that the high rates of coinfections among IDU inmates emphasise the need to harm-reduction policy across prisons in Spain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rhodes T, Hunter GM, Stimson GV, Donoghoe MC, Noble A, Parry J, Chalmers C. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: Injecting careers, positivity and risk behaviour. Addiction 1996; 91: 1457–1467.
Stark K, Muller R, Bienzle U, Guggenmoos-Holzmann I. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS 1996; 10: 311–317.
Zeldis JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N. Seroepidemiology of viral infections among intravenous drug users in northern California. Western J Med 1992; 156: 30–35.
Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. Med J Australia 1997; 166: 127–130.
Rotily M, Galinier-Pujol A, Obadia Y, Moatti JP, Toubiana P, Vernay-Vaisse C, Gastaut JA. HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons. AIDS 1994; 8: 1341–1344.
Caylá JA, Marco A, Bedoya A, Vidal R, López-Colomés JL, Gatell JM. Differential characteristics of AIDS patients with a history of imprisonment. Int J Epidemiol 1995; 24: 1188–1196.
Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies-specificity, sensitivity and applications. JAMA 1985; 203: 221–225.
Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996; 49: 907–916.
Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125–137.
Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev 1994; 16: 33–50.
Dixon WJ. BMDP statistical software manual. Berkeley: University of California Press, 1992.
Behrendt C, Kending N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for HIV in a prison population with a high prevalence of HIV. Am J Epidemiol 1994; 139: 918–926.
Dye S, Isaacs C. Intravenous drug misuse among prison inmates: Implications for spread of HIV. Br Med J 1991; 302: 1506.
Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Muñoz A. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991; 265: 1129–1132.
Dufour A, Alary M, Poulin C, Allar F, Noel L, Trottier G, Lépine D, Hankins C. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996; 10: 1009–1015.
Smyth R, Keenan E, Dorman A, O'Connor J. Hepatitis C infection among injecting drug users attending the National Drug Treatment Centre. Irish J Med Sci 1995; 164: 267–268.
Grupo Noroeste para el estudio de la Hepatitis por virus C en el medio penitenciario. Seroprevalencia de infección por virus C de la hepatitis en población reclusa del Noroeste de España a su ingreso en prisión, [Seroprevalence of infection by hepatitis C virus on entry to prison in the prison population in the northeast of Spain]. Revista Española de Salud Pública 1998; 72: 43–51.
Muller R, Stark K, Guggenmoos-Holzmann I, Wirth D, Bienzle U. Imprisonment: A risk factor for HIV infection counteracting education and prevention programmes for intravenous drug users. AIDS 1995; 9: 183–190.
Shewan D, Gemmell M, Davies JB. Behavioral change amongst drug injectors in Scottish prisons. Soc Sci Med 1994; 39: 1585–1586.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pallás, J.R., Fariñas-Álvarez, C., Prieto, D. et al. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 15, 699–704 (1999). https://doi.org/10.1023/A:1007619614350
Issue Date:
DOI: https://doi.org/10.1023/A:1007619614350